Tag results:

tumor initiating cells

Faciogenital Dysplasia 5 Supports Cancer Stem Cell Traits in Basal-Like Breast Cancer by Enhancing EGFR Stability

[Science Translational Medicine] Scientists performed the basal-like breast cancers (BLBCs) tissue microarray–based immunohistochemical analysis and showed that Faciogenital Dysplasia 5 abundance was associated with poor prognosis in BLBCs.

Downregulation of MUC15 by miR-183-5p.1 Promotes Liver Tumor-Initiating Cells Properties and Tumorigenesis via Regulating C-MET/PI3K/AKT/SOX2 Axis

[Cell Death & Disease] Researchers reported that expression of mucin 15 (MUC15) was downregulated in liver tumor-initiating cells, chemoresistance, and recurrent HCC samples.

Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine Starvation

[Advanced Science] Based on clinical samples, patient-derived cells, and cell lines, it was found that liver cancer cells displayed stem-like characteristics upon glutamine shortage due to maintaining the stemness of tumor initiating cells (TICs) and even promoting transformation of non-TICs into stem-like cells by glutamine starvation.

BMI1 Nuclear Location Is Critical for RAD51-Dependent Response to Replication Stress and Drives Chemoresistance in Breast Cancer Stem Cells

[Cell Death & Disease] Scientists depicted the mechanism of breast cancer stem cells’ (bCSCs) response to replication stress (RS) and its clinical implication, and demonstrated that bCSCs presented a limited level of RS compared with non-bCSCs in patient samples.

Notch Pathway Inhibition Mediated by Arsenic Trioxide Depletes Tumor Initiating Cells in Small Cell Lung Cancer

[Molecular Biology Reports] Researchers demonstrated that As2O3 had a remarkable inhibitory effect on tumor initiating cells of small cell lung cancer both in vitro and in vivo, and the mechanism might have involved the down-regulation of Notch pathway

EHMT1/EHMT2 in EMT, Cancer Stemness and Drug Resistance: Emerging Evidence and Mechanisms

[FEBS Journal] The authors discuss cancer-type specific molecular targets, context-dependent mechanisms and future directions of research in targeting EHMT1/EHMT2 for the treatment of cancer.

Popular